Rituximab for Idiopathic Nephrotic Syndrome

NCT04494438 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Istituto Giannina Gaslini